Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin.
Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin. Blood. 2025 May 28.
PMID: 40435412
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia. Blood Adv. 2025 May 13; 9(9):2144-2152.
PMID: 39928953
Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia.
Guideline-concordant treatment among adolescents and young adults with acute lymphoblastic leukemia. JNCI Cancer Spectr. 2025 Apr 30; 9(3).
PMID: 40238217
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial. Blood Cancer J. 2025 Apr 03; 15(1):55.
PMID: 40180903
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts.
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts. Blood Adv. 2025 Mar 25; 9(6):1442-1451.
PMID: 39853316
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia. Blood. 2025 Mar 13; 145(11):1182-1194.
PMID: 39791601
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study.
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study. Cancer. 2025 Feb 15; 131(4):e35750.
PMID: 39916320
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia. Blood. 2025 Feb 06; 145(6):577-589.
PMID: 39374521
Health insurance continuity and mortality in children, adolescents, and young adults with blood cancer.
Health insurance continuity and mortality in children, adolescents, and young adults with blood cancer. J Natl Cancer Inst. 2025 Feb 01; 117(2):344-354.
PMID: 39276159
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults.
Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults. Blood Adv. 2025 Jan 28; 9(2):280-290.
PMID: 39531060